124 related articles for article (PubMed ID: 36999876)
1. Improved efficacy of eugenol and
Dąbrowska M; Zielińska-Bliźniewska H; Kwiatkowski P; Guenther S; Łopusiewicz Ł; Kochan E; Pruss A; Sienkiewicz M
Ann Agric Environ Med; 2023 Mar; 30(1):204-210. PubMed ID: 36999876
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory Effect of Eugenol and trans-Anethole Alone and in Combination with Antifungal Medicines on Candida albicans Clinical Isolates.
Dąbrowska M; Zielińska-Bliźniewska H; Kwiatkowski P; Łopusiewicz Ł; Pruss A; Kostek M; Kochan E; Sienkiewicz M
Chem Biodivers; 2021 May; 18(5):e2000843. PubMed ID: 33711200
[TBL] [Abstract][Full Text] [Related]
3. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA
Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783
[TBL] [Abstract][Full Text] [Related]
4. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
5. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis.
Jafri H; Ahmad I
J Mycol Med; 2020 Apr; 30(1):100911. PubMed ID: 32008964
[TBL] [Abstract][Full Text] [Related]
6. In vitro synergy of eugenol on the antifungal effects of voriconazole against Candida tropicalis and Candida krusei strains isolated from the genital tract of mares.
Sharifzadeh A; Shokri H
Equine Vet J; 2021 Jan; 53(1):94-101. PubMed ID: 32298479
[TBL] [Abstract][Full Text] [Related]
7. Comparative in vitro activities of seven antifungal drugs against clinical isolates of Candida parapsilosis complex.
Khodavaisy S; Badali H; Meis JF; Modiri M; Mahmoudi S; Abtahi H; Salehi M; Dehghan Manshadi SA; Aala F; Agha Kuchak Afshari S; Lotfali E; Ahangarkani F; Rezaie S
J Mycol Med; 2020 Sep; 30(3):100968. PubMed ID: 32386800
[TBL] [Abstract][Full Text] [Related]
8. The Inhibition of Non-
Mandras N; Roana J; Scalas D; Del Re S; Cavallo L; Ghisetti V; Tullio V
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443525
[TBL] [Abstract][Full Text] [Related]
9. Triazole Evolution of Candida parapsilosis Results in Cross-Resistance to Other Antifungal Drugs, Influences Stress Responses, and Alters Virulence in an Antifungal Drug-Dependent Manner.
Papp C; Bohner F; Kocsis K; Varga M; Szekeres A; Bodai L; Willis JR; Gabaldón T; Tóth R; Nosanchuk JD; Vágvölgyi C; Gácser A
mSphere; 2020 Oct; 5(5):. PubMed ID: 33115837
[TBL] [Abstract][Full Text] [Related]
10. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
Karabıçak N; Alem N
Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
[TBL] [Abstract][Full Text] [Related]
11. The Inhibitory Effect of Human Beta-defensin-3 on
Inthanachai T; Thammahong A; Edwards SW; Virakul S; Kiatsurayanon C; Chiewchengchol D
Immunol Invest; 2021 Jan; 50(1):80-91. PubMed ID: 32316784
[No Abstract] [Full Text] [Related]
12. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
Ozcan SK; Mutlu B; Dündar D; Willke A
Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
[TBL] [Abstract][Full Text] [Related]
13. Synergistic fungicidal activity with low doses of eugenol and amphotericin B against Candida albicans.
Khan SN; Khan S; Misba L; Sharief M; Hashmi A; Khan AU
Biochem Biophys Res Commun; 2019 Oct; 518(3):459-464. PubMed ID: 31443962
[TBL] [Abstract][Full Text] [Related]
14. Interaction of carvacroland voriconazole against drug - resistant Candida strains isolated from patients with candidiasis.
Sharifzadeh A; Shokri H; Abbaszadeh S
J Mycol Med; 2019 Apr; 29(1):44-48. PubMed ID: 30554935
[TBL] [Abstract][Full Text] [Related]
15. Repurposing of Ribavirin as an Adjunct Therapy against Invasive
Yousfi H; Cassagne C; Ranque S; Rolain JM; Bittar F
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31307986
[TBL] [Abstract][Full Text] [Related]
16. Terpenoids inhibit Candida albicans growth by affecting membrane integrity and arrest of cell cycle.
Zore GB; Thakre AD; Jadhav S; Karuppayil SM
Phytomedicine; 2011 Oct; 18(13):1181-90. PubMed ID: 21596542
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and Antifungal Susceptibility of
Badiee P; Boekhout T; Haddadi P; Mohammadi R; Ghadimi-Moghadam A; Soltani J; Zarei Mahmoudabadi A; Ayatollahi Mousavi SA; Najafzadeh MJ; Diba K; Salimi-Khorashad AR; Amin Shahidi M; Ghasemi F; Jafarian H
Microbiol Spectr; 2022 Dec; 10(6):e0245322. PubMed ID: 36445122
[TBL] [Abstract][Full Text] [Related]
18. Sensitization of Candida albicans biofilms to fluconazole by terpenoids of plant origin.
Doke SK; Raut JS; Dhawale S; Karuppayil SM
J Gen Appl Microbiol; 2014; 60(5):163-8. PubMed ID: 25420420
[TBL] [Abstract][Full Text] [Related]
19. Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern.
Bitew A; Abebaw Y
BMC Womens Health; 2018 Jun; 18(1):94. PubMed ID: 29902998
[TBL] [Abstract][Full Text] [Related]
20. Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile.
Sadeghi G; Ebrahimi-Rad M; Mousavi SF; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
J Mycol Med; 2018 Mar; 28(1):51-58. PubMed ID: 29366545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
